Valiant Co

Valiant Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Valiant Co (002643.SZ) as of Nov 18, 2026 is 190.07. In the previous year, Cash Conversion Cycle (CCC) was 260.34 — a change of -26.99% (lower).

Cash Conversion Cycle

190.07

YoY

-26.99%

Last updated:

Cash Conversion Cycle (CCC) of Valiant Co is 2025 190.07 . Cash Conversion Cycle (CCC) of Valiant Co was 2024 260.34 . It decreases by -26.99% lower compared to the previous year.

The Valiant Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
198.09 CNY
Jan 1, 2019
224.72 CNY
Jan 1, 2020
248.38 CNY
Jan 1, 2021
139.82 CNY
Jan 1, 2022
149.12 CNY
Jan 1, 2023
247.06 CNY
Jan 1, 2024
260.34 CNY
Jan 1, 2025
190.07 CNY
The Valiant Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
190.07-26.99%
260.34+5.37%
247.06+65.68%
149.12+6.65%
139.82-43.71%
248.38+10.53%
224.72+13.44%
198.09+23.06%
160.97-21.42%
204.84+178.42%
73.57-43.49%
130.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Cash Conversion Cycle (CCC) of Valiant Co is 190.07 in 2025.

Cash Conversion Cycle (CCC) of Valiant Co changed from 260.34 to 190.07, representing a -26.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Valiant Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Valiant Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Valiant Co

All Key Metrics — Valiant Co